Status:
RECRUITING
Ileal Crohn's Disease and Post-operative Outcome: Prospective Cohort Study of the REMIND Group
Lead Sponsor:
Saint-Louis Hospital, Paris, France
Conditions:
Crohn Disease
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Crohn's disease (CD), a chronic inflammatory process in intestinal segments leads to tissue damage. More than two thirds of CD patients need intestinal resection. Symptomatic clinical recurrence occur...
Detailed Description
Crohn's Disease is a major health issue with a complex etiology and despite available medical treatment, patients endure poor quality of life. The disease 's characterization on a molecular level will...
Eligibility Criteria
Inclusion
- Informed consent obtained before any study-related activities
- A diagnosis of CD, based on clinical, radiologic, endoscopic, or histological evidence.
- Men and women ≥18 years of age
- Required surgical intervention consisting in an ileocecal resection
Exclusion
- Previous history of dysplasia or cancer in the ileum or colon
- Unwillingness or inability to follow the procedures outlined in the protocol
- Pregnant women
Key Trial Info
Start Date :
December 10 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
575 Patients enrolled
Trial Details
Trial ID
NCT03458195
Start Date
December 10 2009
End Date
December 1 2026
Last Update
April 18 2024
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
SART Tilman Hospital
Liège, Belgium
2
Amiens Hospital
Amiens, France, 80054
3
Haut-levêque Hospital
Bordeaux, France, 33
4
Clermont-Ferrand Hospital
Clermont-Ferrand, France, 63003